SynapDx
Latest round
- Series A
Last raised
- Jul 2013
Total raised
- $31M
Investors
- 5
About SynapDx
SynapDx Corp is a biotechnology company focused on developing innovative solutions for health diagnostics and therapeutic interventions.SynapDx Corp specializes in health diagnostics and therapeutic solutions. The company was founded in Southborough, US, and has undergone strategic pivots to enhance its focus on innovative health products. The firm was established by a team of professionals with relevant industry experience.SynapDx specializes in the sale of human growth hormone (HGH) products, catering to a diverse customer base that includes athletes, fitness enthusiasts, and individuals seeking anti-aging benefits. The company's core offerings consist of injectable HGH from reputable brands such as Genotropin, Zptropin, and Norditropin, all of which are lab-tested and verified for safety and effectiveness. These products aim to enhance energy levels, improve physical performance, facilitate recovery, and promote overall vitality. SynapDx markets its products primarily in North America and Europe, ensuring that customers have access to quality HGH options that meet pharmaceutical standards.SynapDx generates revenue through direct-to-consumer sales of its HGH products, structured as individual transactions that involve one-time purchases rather than subscriptions or recurring payments. The pricing model reflects real value, making high-quality HGH accessible to a broader audience. Customers engage with SynapDx by selecting from a variety of HGH products that vary in price based on brand and formulation, allowing for tailored purchasing decisions according to individual needs and budgets. The company is targeting new geographic regions, specifically Asia and South America, potentially by 2025, to broaden its customer base.
Who invested in SynapDx
5 investors across 3 rounds
See all investors in SynapDx
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about SynapDx
Who invested in SynapDx?
SynapDx has 5 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has SynapDx raised?
SynapDx has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did SynapDx last raise money?
SynapDx's most recent round on record is a Series A, in Jul 2013.
What does SynapDx do?
SynapDx Corp is a biotechnology company focused on developing innovative solutions for health diagnostics and therapeutic interventions.
Where is SynapDx headquartered?
SynapDx is headquartered in Southborough, US.
Which VCs invest in companies like SynapDx?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back medical devices & equipment companies at SynapDx's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series A
Raising like SynapDx? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.